Dynamic liver imaging with iron oxide agents: Effects of size and biodistribution on contrast

Magnetic Resonance in Medicine

Volumn 37, Issue 6, 1997, Pages 885-890

  Mandeville, Joseph B ^a   Moore, John ^a   Chesler, David A ^a   Garrido, Leoncio ^a   Weissleder, Ralph ^a   Weisskoff, Robert M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Contrast agents; Iron oxide; Liver; MRI

Indexed keywords

BINDING ENERGY; HADRONS; LIVER; MAGNETIC RESONANCE IMAGING;

BIODISTRIBUTIONS; CONTRAST AGENT; ECHO PLANAR IMAGING; HIGH TEMPORAL RESOLUTION; MEAN PARTICLE DIAMETER; POLYCRYSTALLINE; RECEPTOR BINDING; RELAXATION RATES;

IRON OXIDES;

IRON OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; IMAGE ANALYSIS; KUPFFER CELL; LIVER DISEASE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

EID: 0030996329     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910370613     Document Type: Article

References (26)

1. R. Weissledor, D. D. Stark, Magnetin resonance imaging of the liver. Magn. Reson. Q. 5, 97-121 (1989).
2. R. Weissleder, G. Elizondo, J. Wittenberg, C. Rabito, H. Bemgele, L. Josephson, Ultrasmall superparamagnetic iron oxide (USPIO): characterization of a new class of contrast agents for MR imaging. Radiology 175, 489-493 (1990).
3. R. Weissleder, P. Reimer, A. S. Lee, J. Witlenberg, T. J. Brady, MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. AJR: Am. J. Roentgenol. 155, 1161-1167 (1990).
4. L. Josephson, E. V. Groman, E. Menz, J. M. Luis, H. Bengele, A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn. Resan. Imaging 8, 637-646 (1990).
5. P. Reimer, R. Weissleder, A. Lee, S. Buettner, J. Wittenberg, T. Brady, Asialoglycnprotein receptor function in benign liver disease: evaluation with MR imaging. Radiology 178. 769-774 (1991).
6. D. Pouliquen, J. J. Le Jeune, R. Perdrisot, A. Ermias, P. Jallet, Iron oxide nanouarticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn. Reson, Imaging 9, 275-283 (1991).
7. P. Reimer, K. K. Kwong, R. Weisskoff, M. S. Cohenm T. J. Brady, R. Weissleder, Dynamic signal intensity changes in liver with suporparamagnetic MR contrast agents. J. Magn. Rason. Imaging 2, 177-181 (1992).
8. B. K. Schaffer, C. Linker, M. Papisov, E. Tsai, N. Nossiff, T. Shibata, A. Bogdanov Jr., T. J. Brady, R. Weissleder, MION ASF: biokinetics of an MR receptor agent. Magn. Reson. Imaging 11, 411-417 (1993).
9. 2 relaxation effects. Magn. Reson. Imaging 11, 219-228 (1993).
10. T. Bach-Gansmo, A. K. Fahlvik, A. Ericsson, A. Hemmingsson, Superparamagnetic iron oxide for liver imaging: comparison among three different preparations. Invest Radial 29, 339-344 (1994).
11. A. Blouin, R. P. Bolender, E. R. Weibel, Organelles in nonhepatocytos. J. Cell Biol. 72, 441-455 (1977).
12. L Josephson, J. Lewis, P. Jacobs, P. F. Hahn, D. D. Stark, The effects of iron oxides on proton relaxivity. Magn. Reson. Imaging 6, 647-653 (1988).
13. S. Majumdar, S. Zoghbi, C. F. Pope, J. C. Gore, A quantitative study of relaxation rate enhancement produced by iron oxide particles in polyacrlamide gels and tissue. Magn. Reson. Med. 9, 185-202 (1989).
14. P. A. Hardy, R. M. Henkelman, Transverse relaxation rate enhancement caused by magnetic particulates. Magn. Reson. Imaging 7, 265-275 (1989).
15. R. M. Weisskoff, C. S. Zuo, J. L. Boxerman, B. R. Rosen, Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn. Reson. Mad. 31, 601-610 (1994).
16. T. Shen, R. Weissleder, M. Papisov, A. Bogdanov Jr., T. J. Brady, Monocrystalline iron oxide nanocompounds (MION): physiochemical properties. Magn. Reson. Med. 29, 599-604 (1993).
17. T. T. Shen, A. Bogdanov Jr., A Bogdanov, K. Poss, T. J. Brady, R. Weissleder, Magnetically labeled secretin retains receptor affinity to pancreas acinar cells Bioconjug. Chem. 7, 311-316 (1996).
18. C. W. Jung, R. Weissleder, L. Josephson, H. Bengele, T. J. Brady. Physical properties of MION-46 and AMI-227, in "Proc., ISMRM. 4th Annual Meeting, New York. 1996," p. 1681.
19. J. Harford, G. Ashwell, Assessment of receptor recycling in mammalian hepatocytes: perspectives based on current techniques. Methods Enzymol. 109, 232-246 (1985).
20. A. Villringer, B. R. Rosen, J. W. Belliveau, J. L. Ackerman, R. B. Lauffer, R. B. Buxton, Y.-S. Chao, V. J. Wedeen, T. J. Brady, Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6, 164-174 (1988).
21. M. S. Nender, "A Study of Blood-brain Barrier Permeability Variations in vivo Using Magnetic Resonance Imaging." PhD thesis, Massachusetts Institute of Technology, 1993.
22. C. Crone, The permeability of capillaries in various organs as determined by use of the indicator dilution method. Acta Physiol. Scand. 58, 292-305 (1963).
23. 1 contrast agents: accuracy, precision and water exchange. Magn. Reson. Med. 36, 858-867 (1896).
24. Y. Sugiyarna, M. Hanano, Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body. Pharm Res 6, 192-202 (1989).
25. E. Okon, D. Pouliquen, P. Okon, Z. V. Kovaleva, T. P. Stepanova, S. G. Lavit, B. N. Kudryavtsev, P. Jallet, Biodegradation of magnetite dextran nanoparticles in the rat. Lab. Invest. 71, 895-903 (1984).
26. E. R. Wisner, E. G. Amparo, D. R. Vera, J. M. Brock, T. W. Barlow, S. M. Griffuy, C. Drake, R. W. Katzberg, Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI. J. Comput. Assist. Tomogr. 19, 211-215 (1995).